KMID : 1048120200090040170
|
|
International Journal of Gastrointestinal Intervention 2020 Volume.9 No. 4 p.170 ~ p.176
|
|
Recent developments in endoscopic ultrasound-guided radiofrequency ablation for pancreatic lesions
|
|
Cho Jae-Hee
Jang Sung-Ill Lee Dong-Ki
|
|
Abstract
|
|
|
Radiofrequency ablation (RFA) has been regarded as an established technique to treat various diseases such as hepatocellular carcinoma, renal cell carcinoma and Barret¡¯s esophagus. Although the application of RFA in the pancreas has been limited due to increased risk of adverse events, endoscopic ultrasound-guided RFA (EUS-RFA) has generated interest as a novel minimally invasive treatment modality which combines real-time visualization with a precise localization of the treatment procedure. For over a decade, the optimization of RFA devices have made EUS-RFA relatively safe, and several studies have supported its feasibility. However, there is insufficient evidence to suggest the appropriate indications and to describe long-term outcomes of EUS-RFA for various pancreatic neoplasms such as pancreatic neuroendocrine tumor, ductal adenocarcinoma, and cystic lesions. Therefore, this review focuses on the technical aspects and clinical applications of EUS-RFA for each pancreatic disease.
|
|
KEYWORD
|
|
Endoscopic ultrasound, Pancreatic cystic lesions, Pancreatic neopla, Pancreatic neuroendocrine tumor, Radiofrequency ablation
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|